MESTRONI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 6.752
EU - Europa 4.233
AS - Asia 3.588
SA - Sud America 448
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 15.137
Nazione #
US - Stati Uniti d'America 6.629
SG - Singapore 1.330
PL - Polonia 1.265
IT - Italia 1.053
CN - Cina 790
VN - Vietnam 366
BR - Brasile 345
SE - Svezia 344
HK - Hong Kong 333
DE - Germania 294
FR - Francia 224
BD - Bangladesh 216
NL - Olanda 184
KR - Corea 173
GB - Regno Unito 165
FI - Finlandia 152
RU - Federazione Russa 117
UA - Ucraina 102
IN - India 80
TR - Turchia 79
BG - Bulgaria 72
IE - Irlanda 72
CA - Canada 64
JP - Giappone 40
AR - Argentina 38
CH - Svizzera 33
MX - Messico 33
MA - Marocco 32
ES - Italia 28
BE - Belgio 25
ZA - Sudafrica 25
ID - Indonesia 24
AT - Austria 20
IQ - Iraq 19
SA - Arabia Saudita 18
PK - Pakistan 17
EC - Ecuador 14
IR - Iran 12
CL - Cile 11
CO - Colombia 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 9
GR - Grecia 8
JO - Giordania 8
KG - Kirghizistan 8
PH - Filippine 8
RO - Romania 8
TN - Tunisia 8
KE - Kenya 7
NP - Nepal 7
PT - Portogallo 7
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
MY - Malesia 6
SN - Senegal 6
AZ - Azerbaigian 5
HU - Ungheria 5
JM - Giamaica 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
PY - Paraguay 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
AL - Albania 4
AO - Angola 4
AU - Australia 4
BO - Bolivia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EU - Europa 4
NO - Norvegia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
KW - Kuwait 3
NG - Nigeria 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
Totale 15.117
Città #
Warsaw 1.181
Ashburn 847
Singapore 834
Fairfield 498
Chandler 454
Woodbridge 346
San Jose 333
Hong Kong 322
Houston 278
Ann Arbor 268
Chicago 227
Wilmington 227
Beijing 215
Trieste 214
Seattle 200
Cambridge 185
Los Angeles 171
Seoul 162
Dallas 146
Hefei 125
Ho Chi Minh City 112
Jacksonville 112
Boardman 110
Princeton 106
Council Bluffs 100
Milan 84
Santa Clara 84
Hanoi 81
Helsinki 79
Lauterbourg 76
New York 69
Sofia 69
Columbus 68
Dublin 67
Zgierz 64
Munich 63
Frankfurt am Main 58
London 58
Rome 58
Salt Lake City 50
Izmir 49
Buffalo 48
Moscow 48
São Paulo 41
Amsterdam 40
Dearborn 40
The Dalles 37
Dong Ket 30
Tokyo 30
Redwood City 29
San Diego 29
Düsseldorf 28
Nuremberg 28
Phoenix 28
Elk Grove Village 27
Tampa 27
Guangzhou 25
Lappeenranta 25
Brussels 24
Atlanta 23
Redondo Beach 23
Orem 22
Turku 22
Bremen 21
Toronto 21
Bern 20
Casablanca 20
Falls Church 20
Miano 20
Memphis 19
Turin 19
Da Nang 18
Denver 18
Lancaster 17
Poplar 17
Redmond 17
Sterling 17
Washington 17
Grafing 16
Miami 16
Naples 16
Shanghai 15
Venice 15
Chennai 14
Johannesburg 14
Nanjing 14
Palermo 14
Vienna 14
Stockholm 13
Montreal 12
Bexley 11
Des Moines 11
Madrid 11
San Francisco 11
Baghdad 10
Bari 10
Belgrade 10
Boydton 10
Brooklyn 10
Haiphong 10
Totale 10.082
Nome #
Current understanding of the role of cytoskeletal cross-linkers in the onset and development of cardiomyopathies 521
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 508
Natural History of Dilated Cardiomyopathy in Children 435
Role of Titin Missense Variants in Dilated Cardiomyopathy 424
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 402
Improving cardiac myocytes performance by carbon nanotubes platforms 389
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy 384
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 332
Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation 291
Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C 290
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins 289
Historical Terminology, Classifications, and Present Definition of DCM. 275
The giant protein Titin’s role in cardiomyopathy: genetic, transcriptional, and post translational modifications of TTN and their contribution to cardiac disease 265
Carbon nanotube facilitation of myocardial ablation with radiofrequency energy 256
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 255
Easy fabrication of aligned PLLA nanofibers-based 2D scaffolds suitable for cell contact guidance studies 254
Genetics of Dilated Cardiomyopathy: Clinical Implications 249
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 234
The role of clinical observation: Red flag 6-left ventricular non-compaction 231
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 231
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 227
The role of clinical observation: Red flag 7-syndromic and multi-system cardiomyopathies 225
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 220
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 217
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 215
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 201
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 199
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 189
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 188
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 186
Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes 184
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 181
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 180
Atomic Force Microscopy (AFM) applications in arrhythmo-genic cardiomyopathy 179
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 176
Introduction 175
Viscoelastic behavior of cardiomyocytes carrying LMNA mutations 175
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 173
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 171
Clinical Spectrum of PRKAG2 Syndrome 171
Cellular Biomechanic Impairment in Cardiomyocytes Carrying the Progeria Mutation: An Atomic Force Microscopy Investigation 161
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 158
Prognostic role of exercise intensity in familial Filamin C truncating variants 157
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 156
AFM macro-probes to investigate whole 3D cardiac spheroids 154
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 154
Lamin A/C Cardiomyopathy: Implications for Treatment 149
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy 146
Carbon Nanotubes for Cardiac Applications 142
Molecular and Cellular Mechanisms in Heart Failure 140
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators 136
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients 135
Microfabricated cantilevers for parallelized cell-cell adhesion measurements 135
The Arrhythmic Phenotype in Cardiomyopathy 134
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy 134
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids 131
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 125
null 121
The genetic architecture of Plakophilin 2 cardiomyopathy 120
Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges 115
CARBON NANOTUBE SCAFFOLDS FOR CARDIAC TISSUE ENGINEERING 114
Compromised Biomechanical Properties, Cell–Cell Adhesion and Nanotubes Communication in Cardiac Fibroblasts Carrying the Lamin A/C D192G Mutation 114
null 112
Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubes 109
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 106
null 103
Gold Nanoparticle-Functionalized Reverse Thermal Gel for Tissue Engineering Applications 103
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis 102
Valutazione dell’ereditarietà e analisi molecolare alla luce delle nuove linee guida europee sulla cardiomiopatia ipertrofica 102
Genetic causes of dilated cardiomyopathy 97
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy 97
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 92
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis 85
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 76
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 73
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 70
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 61
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 56
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 51
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 37
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 21
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 9
RBM20 Truncating Variants and Human Cardiomyopathy 8
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry 5
Totale 15.580
Categoria #
all - tutte 43.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022941 68 79 64 47 52 82 47 27 103 91 56 225
2022/20231.250 105 172 136 198 112 197 17 112 124 18 40 19
2023/2024902 58 49 66 67 73 118 143 128 18 26 93 63
2024/20252.174 24 151 200 169 183 157 119 124 270 305 238 234
2025/20266.024 865 345 541 545 481 436 726 198 539 678 393 277
2026/202733 33 0 0 0 0 0 0 0 0 0 0 0
Totale 15.580